Summary. An ampouled freeze-dried preparation of bovine pituitary luteinizing hormone (bLH), coded EHC-bLH-1, has been evaluated in an international collaborative study and shown to be suitable and sufficiently stable to serve as a standard for bLH.
Introduction
Immunoassay of bovine luteinizing hormone (bLH) is applied widely in research work on breeding and fertilization in cattle. A number of highly purified preparations are available from the United States National Institutes of Health and the United States Department of Agriculture. However, over the years these materials have been widely used as working standards and have consequently been replaced at frequent intervals so that maintaining a continuous defined unitage has been difficult.
In 1979 a group of experts from 6 different European countries and a representative of the USDA, convened in a Workshop sponsored by the European Community Committee, recognized the need for international standards for animal hormones. The results of this workshop have been reported previously (van de Wiel, 1983 ).
The present communication describes an international collaborative study of a preparation of bovine LH, in ampoules coded EHC-bLH-1, subsequently established as the First International Standard of Luteinizing Hormone, Bovine, for immunoassay.
The study was organized with the following aims: (1) to calibrate the ampouled bLH preparation coded EHC-bLH-1 against a current reference preparation, (AFP-5500), by means of in-vivo bioassay, in-vitro bioassay, radioreceptor assay and immunoassay and to assign a unitage to the ampoules; and (2) to assess the stability of EHC-bLH-1 by an accelerated degradation study. (WHO, 1978) . A weighed portion (19-7 mg) of the bLH was dissolved in 985 ml of a solution containing 0-2% (w/v) peptidase-free bovine serum albumin (Boseral, grade "Pur", Organon, Oss, The Netherlands) and 1% (w/v) lactose. This solution was passed through membrane filters (mean pore diameter 0-45 and 0-22 pm, respectively), and aliquants of 1 0 ml were distributed into ampoules. The ampouled solution was lyophilized, and after secondary desiccation over phosphorus pentoxide the ampoules were sealed by heat fusion of the glass after evacuation and stored at -20°Cinthedark.
FSH contamination was found to be <01 units NIH-FSH-S1 (prepared from sheep pituitary glands) per ampoule as tested by the augmented ovarian weight gain test and by radioimmunoassay according to Cheng (1978 (Finney, 1978) . Responses equivalent to either the minimum or maximum response obtainable with the assay system were omitted from analysis.
Estimates of potency obtained by immunoassays and receptor assays were combined within each laboratory to give the geometric mean potency and the weight of the laboratory mean was based on the reciprocal of the variance of the log potencies combined.
Estimates of potency were assessed for heterogeneity using a 2 test. Homogeneous estimates were combined to give a weighted geometric mean. Heterogeneous estimates were examined to determine the source of heterogeneity; if they were combined, such estimates were combined as unweighted geometric means, and the variability computed as the variance of the combined log potencies.
Relative degradation rates were assumed to be related to temperature of storage of thermally degraded samples by the Arrhenius equation and a maximum likelihood approach was used to predict the rate of degradation under normal storage conditions (Kirkwood, 1977 (Parlow, 1974) .
Immunoassays and receptor assays. The log dose-logit response lines for the various preparations obtained in immunoassays and receptor assays were generally linear. In a few cases apparent non-linearity was due to deviating responses at the extreme ends of the dose-response curves and for these assays only the responses between 15 and 85% of the initial binding were considered. No significant non-parallelism was noted. Calibration of EHC-bLH-1 in terms of USDA-bLH-B-5
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The laboratory mean estimates of EHC-bLH-1 in terms of USDA-bLH-B-5 with confidence limits are given in Table 2 and individual estimates are illustrated in Fig. 1 In some assays participants included solutions of USDA-bLH-B-5 or EHC-bLH-1 which had been kept frozen. In no instance was there a significant difference in potency between the freshly prepared and the frozen solution. 
Calibration of EHC-bLH-1 in terms of local standards
Estimates of the bLH content of EHC-bLH-1 in terms of the various local standards are given in Table 3 . These estimates varied, depending on the local standard and the assay method. However, the overall results were similar to those given by the calibration in terms of USDA-bLH-B-5. Assays of ampoules of EHC-bLH-1 after storage at elevated temperatures suggested that the material has satisfactory stability at -20°C.
